Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Guselkumab loss of exclusitivy?Does food increase lipitor's absorption?Dabrafenib mesylate when the patent is expiring in india?How long have hydroxyzine pamoate been on the market?Prolia and osteonecrosis?
See the DrugPatentWatch profile for ruxolitinib
The provided information doesn’t include any FDA approval status for an Apotex ruxolitinib generic, so the answer can’t be verified from these materials.
To confirm FDA approval, check the FDA’s relevant databases for the specific drug strength and dosage form (e.g., tablet vs. extended-release form). The most direct sources are: - The FDA’s Orange Book listing for ruxolitinib products (shows whether a generic is approved and who markets it). - FDA drug approval press releases or labeling posted on Drugs@FDA for the exact product and applicant.
Sometimes the application sponsor or marketing authorization holder differs from the corporate name a search might show (for example, subsidiaries or different label holders). That means you’ll need to verify the applicant/holder listed for the specific ruxolitinib generic product, not just the company name you see in news or filings.
If you share either (1) the exact Apotex product name/strength/dosage form you mean, or (2) a link or screenshot from the Orange Book entry/Drugs@FDA page, I can tell you whether that specific Apotex ruxolitinib generic is listed as FDA-approved based on the provided details.
No sources were provided in the prompt.
Other Questions About Ruxolitinib :